Navigation Links
Banyan Biomarkers Announces Issuance of U.S. Patent for Biomarkers for Traumatic Injury
Date:12/12/2008

Banyan Biomarkers, Inc. announced today that the U.S. Patent and Trademark Office has granted U.S. Patent No. 7,456,027, “Proteolytic Biomarkers for Traumatic Injury to the Nervous System”, licensed exclusively by Banyan Biomarkers from the University of Florida with the company as co-inventor. This newly issued patent describes a method of determining the presence of neural injury through the measurement of proteolytic breakdown products of microtubule-associated proteins (MAP). The company has developed Enzyme Linked Immunosorbent Assays (ELISAs) that detect MAP and is conducting a clinical study designed to evaluate MAP as an indicator of traumatic brain injury (TBI). The company’s goal is to seek FDA regulatory review for the use of MAP as an aid in the detection and monitoring of TBI.

ALACHUA, Fla. (Business Wire EON) December 12, 2008 -- Gary Ascani, Chief Executive Officer of Banyan Biomarkers, Inc., commented, "We are very pleased with the addition of this patent to Banyan's intellectual property portfolio of TBI biomarkers. With nearly 2 million people experiencing TBI annually in the United States and no available point-of-care diagnostic test, Banyan is paving the way in establishing the leadership position in the discovery, validation and development of products for the detection of traumatic brain injury."

Banyan Biomarkers also has exclusive licenses from the University of Florida for U.S. Patent no. 7,291,710 "Detection of Spectrin and Spectrin Proteolytic Cleavage Products in Assessing Nerve Cell Damage" and U.S. Patent No. 7,396,654 "Neural Proteins as Biomarkers for Traumatic Brain Injury."

To learn more about Banyan Biomarkers, Inc., visit http://www.banyanbio.com/.

Read the full stor
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

2

GOOD

Page: 1 2

Related biology technology :

1. Ingenuity Systems Joins Biomarkers Consortium
2. Decision Biomarkers Awarded U.S. Patent for Protein Array Surface Chemistry
3. Decision Biomarkers Launches System for Faster, Easier Quantification of Protein Biomarkers
4. Genetic Engineering & Biotechnology News reports on cancer biomarkers
5. GeneNews reports positive results from validation study of colorectal cancer biomarkers in late-breaking abstract at AACR
6. When to Wait and When to Treat? New Program Will Search for Biomarkers in Men With Prostate Cancer to Help Find an Answer
7. Thomson Reuters Launches New Biomarkers Solution
8. Decision Biomarkers Inc Announces Formation of Scientific Advisory Board
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
11. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology Technology:HemaQuest Pharmaceuticals Presents Promising Results in Sickle Cell Disease and Beta Thalassemia 2HemaQuest Pharmaceuticals Presents Promising Results in Sickle Cell Disease and Beta Thalassemia 3New technology could boost disease detection tests' speed and sensitivity 2Myriant Technologies LLC Selected for $50 Million Award for Succinic Acid Biorefinery Project 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6
Breaking Biology News(10 mins):National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 2National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 3National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 4Superior offspring without genetic modification 2Researchers finds hidden sensory system in the skin 2Researchers finds hidden sensory system in the skin 3A Sacred Celebration 3A Georgetown School of Medicine Honors Donors 48227 1A Sacred Celebration 3A Georgetown School of Medicine Honors Donors 48227 2VivoMetrics 28R 29 Introduces Next Generation LifeShirt Prototype a Smart Garment That Delivers Real time Vital Signs Remotely to Healthcare Provider 4569 1VivoMetrics 28R 29 Introduces Next Generation LifeShirt Prototype a Smart Garment That Delivers Real time Vital Signs Remotely to Healthcare Provider 4569 2VivoMetrics 28R 29 Introduces Next Generation LifeShirt Prototype a Smart Garment That Delivers Real time Vital Signs Remotely to Healthcare Provider 4569 3VivoMetrics 28R 29 Introduces Next Generation LifeShirt Prototype a Smart Garment That Delivers Real time Vital Signs Remotely to Healthcare Provider 4569 4Lack of Sleep Can Raise Blood Pressure Over Time 48223 1Lack of Sleep Can Raise Blood Pressure Over Time 48223 2